BOTHELL, Wash., Aug. 28, 2019 /PRNewswire/ -- BioLife Solutions, Inc. (NASDAQ: BLFS), a leading developer and supplier of a portfolio of best-in-class bioproduct

HOUSTON, Aug. 28, 2019 /PRNewswire/ -- Rescued Pets Movement Inc., the largest homeless animal rehabilitation and transport nonprofit in the United States, today announced its Fur Ball Gala 2019 that will honor Julie and Brook Brookshire with the inaugural Leslie L. Alexander Lifesaving Award.&nb

COLLEYVILLE, Texas, Aug. 28, 2019 /PRNewswire/ -- Bone Solutions Inc., announces a private label licensing agreement with Onkos Surgical covering OsteoCrete® technology — the first FDA (510k) cleared magnesium-based bone void filler in the orthopedic marketplace, designed to assist with bone repair and regenera

SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- Parks Associates hosted the sixth annual Connected Health Summit: Independent L

SANFORD, N.C., Aug. 28, 2019 /PRNewswire/ -- DisposeRx, the at-home medication disposal solution, released a statement today regarding the Environmental Protection Agency's (EPA's) final rule for hazardou

JERUSALEM, Aug. 28, 2019 /PRNewswire/ -- BiondVax Pharmaceuticals Ltd. (NASDAQ: BVXV), a Phase 3 clinical stage biopharmaceutical company focused on developing and commercializing M-001, a universal flu vaccine candidate, today announced the appointment of a new Chairman of the Board of Directors and financial results for the quarter ended June 30,

—  Adds an ultra-premium brand to TerrAscend's global portfolio of operations across multiple U.S. States, Canada and the EU.--- Daniel Wacks and Jeremy Cohen to continue leading State Flower TORONTO, Aug. 28, 2019

SOUTH SAN FRANCISCO, Calif., Aug. 28, 2019 /PRNewswire/ -- Rigel Pharmaceuticals, Inc. (Nasdaq:RIGL) today announced that Raul Rodriguez, the company's president and chief executive officer, is scheduled to participate in a panel discussion at Citi's 14th Annual Biotech Conference in Boston, MA

IRVINE, Calif., Aug. 28, 2019 /PRNewswire/ -- BIOLASE, Inc. (NASDAQ: BIOL), the global leader in dental lasers, today announced it has been invited to participate at the 4th Annual Dougherty & Company Institutional Investor Conference being held September 5, 2019 at the Millennium Hotel in M

SAN DIEGO, Aug. 28, 2019 /PRNewswire/ -- Viking Therapeutics, Inc. ("Viking") (NASDAQ: VKTX), a clinical-stage biopharmaceutical company focused on the development of novel therapies for metabolic and endocrine disorders, today announced that the company will participate in two upcoming investor conferences.